Login

Anders Hinsby, CEO of Orphazyme 00:00:00

Share On Facebook Share On Twitter

Navigating the rare disease space: Insights from Orphazyme's CEO

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Harmonic Inc company culture was rated poorly by employees, with CEO Patrick Harshman receiving an F (56/100), placing him in the bottom 5%.
00:10:00
Analyzing Market Opportunities: Insights into the Foord Equity Fund | Cobie Legrange - Fundamental Analyst, Acsis
00:10:00
Toro Gold: From Discovery to Production in Senegal and Expanding Exploration in Côte d'Ivoire
00:10:00
Triumph Gold Corp: Yukon-Based Gold and Copper Exploration and Development Company
00:10:00
investing in deep tech ventures that accelerate the world|Derek Handley,Managing Partner,Aera VC
00:10:00
As China's Linklogis debuts on the Hong Kong stock market, Chairman and CEO Song Qun reveals the supply chain fintech company's future ambitions.
00:10:00
Maximizing Long-Term Returns with Strategic Investment Discipline
00:10:00
Dewet Moser: Introductory Remarks and Q&A Session at the News Conference on June 23, 2021
00:10:00
Uncovering Hidden Assets in Divorce: Expert Tips and Advice
00:10:00
This episode explores growth opportunities, sustainability highlights, and the market outlook for growth equity investments in alternative assets.
00:10:00
Leading the Transition: Insights from Nicolai Tangen, CEO of Norway's $1.6T Wealth Fund | Nicolai Tangen - CEO, Norges Bank Investment Management
00:10:00
Intrepid Metals Reports Strong Drill Results at Corral Copper Property

© 2017 - Neuhu+